Comparative phenotypic and CARD15 mutational analysis among African American, Hispanic, and white children with Crohn's disease

Inflammatory Bowel Diseases

Volumn 11, Issue 7, 2005, Pages 631-638

  Kugathasan, Subra ^a   Loizides, Anthony ^b   Babusukumar, Umesh ^a   McGuire, Erin ^a   Wang, Tao ^a   Hooper, Pleasant ^c   Nebel, Justin ^a   Kofman, Galina ^b   Noel, Richard ^a   Broeckel, Ulrich ^a   Tolia, Vasundhara ^d  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Louisiana Office of Public Health   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African american; CARD15; Children; Crohn's disease; Genetics; Hispanic

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; ALLELISM; ARTICLE; CARD15 GENE; CAUCASIAN; CHILD; COLON; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ETHNIC DIFFERENCE; FEMALE; FUNCTIONAL ANATOMY; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HISPANIC; HUMAN; ILEUM; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES;

ADOLESCENT; AFRICAN AMERICANS; AGE OF ONSET; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HISPANIC AMERICANS; HUMANS; INFANT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; UNITED STATES;

EID: 21844440348     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MIB.0000171279.05471.21     Document Type: Article

References (40)

1. Calkins BM, Mendeloff AI. Epidemiology of inflammatory bowel disease. Epidemiol Rev. 1986;8:60-91.
2. Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-1517.
3. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182-205.
4. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411: 603-606.
5. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603.
6. Ahmad T, Armuzzi A, Bunce, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology. 2002;122: 854-866.
7. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology. 2002;122:867-874.
8. Hampe J, Grebe J, Nikolaus S, et al. Association of NOD2 (CARD15) genotype with clinical course of Crohn's disease: a cohort study. Lancet. 2002;359:1661-1665.
9. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002;70:845-857.
10. Vermeire S, Wild G, Kocher K, et al. CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet. 2002;71:74-83.
11. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology. 2002;123: 86-91.
12. Croucher PJ, Mascheretti S, Hampe J, et al. Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet. 2003;11:6-16.
13. Guo QS, Xia B, Jiang Y, et al. NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. World J Gastroenterol. 2004;10:1069-1071.
14. Kugathasan S, Collins N, Maresso K, et al. CARD15 gene mutations and risk for early surgery in pediatric-onset Crohn's disease. Clin Gastroenterol Hepatol. 2004;2:1003-1009.
15. Tomer G, Ceballos C, Concepcion E, et al. NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease. Am J Gastroenterol. 2003;98:2479-2484.
16. Bonen D, Nicolae D, Moran T, et al. Racial differences in NOD2 variation; characterization of NOD2 in African-American with Crohn's disease. Gastroenterology. 2002;122(suppl):A29.
17. Mendeloff AI, Monk M, Siegel CI, et al. Some epidemiological features of ulcerative colitis and regional enteritis. A preliminary report. Gastroenterology. 1966;51:748-756.
18. Rogers BH, Clark LM, Kirsner JB. The epidemiologic and demographic characteristics of inflammatory bowel disease: an analysis of a computerized file of 1400 patients. J Chronic Dis. 1971;24:743-773.
19. Kurata JH, Kantor-Fish S, Frankl H, et al. Crohn's disease among ethnic groups in a large health maintenance organization. Gastroenterology. 1992;102:1940-1948.
20. Paul H Jr, Barnes RW, Reese VE, et al. Crohn's disease in black patients. J Natl Med Assoc. 1990;82:709-712.
21. Ogunbi SO, Ransom JA, Sullivan K, et al. Inflammatory bowel disease in African-American children living in Georgia. J Pediatr. 1998;133: 103-107.
22. Moreno JM, Rubio CE, Torres EA. Inflammatory disease of the gastrointestinal tract at the University Hospital, Medical Center, Puerto Rico. 1980-87. Bol Asoc Med P R. 1989;81:214-218.
23. Micames C, Zaiter J, Nigaglioni A. Clinico-epidemiological features of 102 consecutive cases of ulcerative colitis in Puerto Rico. Bol Asoc Med P R. 1983;75:106-109.
24. Appleyard CB, Hernandez G, Rios-Bedoya CF. Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm Bowel Dis. 2004;10: 106-111.
25. Simsek H, Schuman BM. Inflammatory bowel disease in 64 black patients: analysis of course, complications, and surgery. J Clin Gastroenterol. 1989;11:294-298.
26. Straus WL, Eisen GM, Sandler RS, et al. Crohn's disease: does race matter? The Mid-Atlantic Crohn's Disease Study Group. Am J Gastroenterol. 2000;95:479-483.
27. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6: 8-15.
28. Chaisomchit S, Wichajarn R, Chowpreecha S, et al. A simple method for extraction and purification of genomic DNA from dried blood spots on filter paper. Southeast Asian J Trop Med Public Health. 2003;34: 641-645.
29. Taub JW, Ge Y. The prenatal origin of childhood acute lymphoblastic leukemia. Leuk Lymphoma. 2004;45:19-25.
30. Goldman CD, Kodner U, Fry RD, et al. Clinical and operative experience with non-Caucasian patients with Crohn's disease. Dis Colon Rectum. 1986;29:317-321.
31. Mekhjian H, Switz D, Watts H. National cooperative Crohn's disease study: Factors determining recurrence of Crohn's disease after surgery. Gastroenterology. 1979;77:907.
32. Summers RW, Switz DM, Sessions JT Jr, et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology. 1979; 77:847-869.
33. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999;340: 1398-1405.
34. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002;359: 1541-1549.
35. Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004;350:876-885.
36. Markowitz JF. Therapeutic efficacy and safety of 6-mercaptopurine and azathioprine in patients with Crohn's disease. Rev Gastroenterol Disord. 2003;3(Suppl 1):S23-S29.
37. Linares de la Cal JA, Canton C, Hermida C, et al. Estimated incidence of inflammatory bowel disease in Argentina and Panama (1987-1993). Rev Esp Enferm Dig. 1999;91:277-286.
38. Zouiten-Mekki L, Zaouali H, Boubaker J, et al. CARD15/NOD2 in a Tunisian population with Crohn's disease. Dig Dis Sci. 2005;50:130-135.
39. Abreu MT, Taylor KD, Lin YC, et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology. 2002; 123:679-688.
40. Pfaff CL, Parra EJ, Bonilla C, et al. Population structure in admixed populations: effect of admixture dynamics on the pattern of linkage disequilibrium. Am J Hum Genet. 2001;68:198-207.